In this free webinar, gain insights into protocol design for new and novel therapies in oncology, including adaptive trial designs and data-driven approaches to optimize trial outcomes and patient safety. The featured speakers will discuss strategies for improving patient access and diversity in oncology clinical trials, including initiatives to address barriers and engage underserved populations. Attendees will gain an understanding of the implications of the changing regulatory landscape for oncology clinical trials.
Toronto, June 28, 2023 /PRNewswire-PRWeb/ --In an effort to illuminate and discuss the challenging aspects of clinical trials in oncology, a free webinar titled "Innovating Oncology Trials: Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges" is set to take place.
This webinar aims to shed light on three challenging aspects of clinical trials in oncology: The need for innovative study design for novel therapies; Patient access and diversity; And navigating the ever-changing regulatory landscape.
These topics have become increasingly important as the continued development of precision medicines has led to smaller study populations associated with higher uncertainty on the evidence-base for approval and reimbursement decision-making, while at the same time broad patient access and the external validity of the data need to be ensured. This force-field warrants clever thinking about study design and making adequate use of the evolving regulatory environment.
The webinar features a distinguished panel of speakers from ProPharma, all of whom bring a wealth of experience and knowledge to the table. The speakers include Robert Rachford, Vice President of Biostatistics and Programming; Kimberly Futch, Director of Clinical Operations Strategy; Shelby Stillwagon, Sr Director of Decentralized Clinical Trials; and Paula van Hennik, Clinical Group Head of Regulatory Sciences.
Through case studies and detailed discussions, the webinar promises to offer valuable insights into the intricacies of oncology trials, including those related to personalized medicine, immunotherapies and targeted treatments.
ProPharma, a leading Research Consulting Organization (RCO) in the pharmaceutical industry with a strong focus on oncology, is partnering with Xtalks in hosting this important event.
The free webinar is scheduled for Tuesday, July 11, 2023, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit Innovating Oncology Trials: Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
Share this article